help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1350
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/4/1428    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dentice, M.
Right arrow Articles by Macchia, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dentice, M.
Right arrow Articles by Macchia, P. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
*Substance via MeSH
*Genetics Home Reference
Hazardous Substances DB
*THYROGLOBULIN
Related Collections
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 4 1428-1433
Copyright © 2006 by The Endocrine Society


RAPID COMMUNICATION

Missense Mutation in the Transcription Factor NKX2–5: A Novel Molecular Event in the Pathogenesis of Thyroid Dysgenesis

Monica Dentice1, Viviana Cordeddu1, Annamaria Rosica, Alfonso Massimiliano Ferrara, Libero Santarpia, Domenico Salvatore, Luca Chiovato, Anna Perri, Lidia Moschini, Cristina Fazzini, Antonella Olivieri, Pietro Costa, Vera Stoppioni, Mariangiola Baserga, Mario De Felice, Mariella Sorcini, Gianfranco Fenzi, Roberto Di Lauro, Marco Tartaglia and Paolo Emidio Macchia

Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica (M.D., A.M.F., D.S., G.F., P.E.M.) and Dipartimento di Biologia e Patologia Cellulare e Molecolare L. Califano (L.S., R.D.L.), Università degli Studi di Napoli Federico II, 80131 Naples, Italy; Dipartimento di Biologia Cellulare e Neuroscienze, Istituto Superiore di Sanità (V.C., C.F., A.O., M.S., M.T.), 00161 Rome, Italy; Stazione Zoologica A. Dohrn, CEINGE (A.R., M.D.F., R.D.L.), 80145 Naples, Italy; Fondazione S. Maugieri, IRCCS (L.C.), 27100 Pavia, Italy; Dipartimento di Endocrinologia e Metabolismo, Ortopedia e Traumatologia, Medicina del Lavoro, Università di Pisa (A.P.), 56124 Pisa, Italy; Istituto di Puericoltura, Università La Sapienza (L.M., P.C.), 00185 Rome, Italy; Centro Screening Neonatale, Ospedale Santa Croce (V.S.), 61132 Fano, Italy; and Dipartimento di Medicina Sperimentale, Università degli Studi della Magna Grecia (M.B.), Catanzaro, Italy

Address all correspondence and requests for reprints to: Dr. Paolo E. Macchia, Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Università di Napoli Federico II, Via S. Pansin, 5, 80131 Naples, Italy. E-mail: pmacchia{at}unina.it.

Abstract

Context: Congenital hypothyroidism (CH) is a common endocrine disorder with an incidence of 1:3000–4000 at birth. In 80–85% of cases, CH is caused by defects in thyroid organogenesis, resulting in absent, ectopically located, and/or severely reduced gland [thyroid dysgenesis (TD)]. Mutations in genes controlling thyroid development have demonstrated that in a few cases, TD is a Mendelian trait. However, accumulating evidence supports the view that the genetics of TD are complex, possibly with a polygenic/multifactorial basis. A higher prevalence of congenital heart disease has been documented in children with CH than in the general population. Such an association suggests a possible pathogenic role of genes involved in both heart and thyroid development. NKX2–5 encodes a homeodomain-containing transcription factor with a major role in heart development, and mutations affecting this gene have been reported in individuals with congenital heart disease.

Objective: In the present work we investigated the possible involvement of NKX2–5 mutations in TD.

Results: Our results indicate that Nkx2–5–/– embryos exhibit thyroid bud hypoplasia, providing evidence that NKX2–5 plays a role in thyroid organogenesis and that NKX2–5 mutations contribute to TD. NKX2–5 mutational screening in 241 patients with TD allowed the identification of three heterozygous missense changes (R25C, A119S, and R161P) in four patients with TD. Functional characterization of the three mutations demonstrated reduced DNA binding and/or transactivation properties, with a dominant-negative effect on wild-type NKX2–5.

Conclusion: Our results suggest a previously unknown role of NKX2–5 in the pathogenesis of TD.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
E. Al Taji, H. Biebermann, Z. Limanova, O. Hnikova, J. Zikmund, C. Dame, A. Gruters, J. Lebl, and H. Krude
Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism
Eur. J. Endocrinol., May 1, 2007; 156(5): 521 - 529.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society